## ARE: Alexandria Real Estate Equities, Inc. - XLRE: Real Estate

### Executive Summary

No thesis match: MRS_10 2.7% below STRENGTH zone (3.0-6.0%); PEG 844.20 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($46.57)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bearish (Bullish: 1, Bearish: 9)

**1. Deadline Alert: Alexandria Real Estate Equities, Inc. (ARE)**
- Source: GlobeNewswire | 20260105T190802 | Bearish | Relevance: 100%
- Glancy Prongay & Murray LLP reminds investors of Alexandria Real Estate Equities, Inc. (ARE) about an upcoming January 26, 2026 deadline to file a lead plaintiff motion in a class action lawsuit. This lawsuit alleges that Alexandria made materially false and misleading statements regarding its Long Island City property's value and growth prospects, leading to a significant stock price drop after a real estate impairment charge was disclosed. Investors who suffered losses on their Alexandria investments during the Class Period (January 27, 2025, to October 27, 2025) are urged to contact the firm.

**2. SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Alexandria Real Estate Equities, Inc. (NYSE: ARE)**
- Source: GlobeNewswire | 20260105T140756 | Bearish | Relevance: 100%
- Bernstein Liebhard LLP has announced the filing of a securities class action lawsuit against Alexandria Real Estate Equities, Inc. (NYSE: ARE) on behalf of investors who purchased shares between January 27, 2025, and October 27, 2025. The lawsuit alleges that the company made misrepresentations regarding its Long Island City property. Shareholders who wish to serve as lead plaintiff must file papers by January 26, 2026.

**3. Alexandria Real Estate Equities, Inc. Celebrates 32 Years of Pioneering Leadership in Life Science Real Estate and Consequential Impact on Advancing Human Health**
- Source: PR Newswire | 20260105T130735 | Bullish | Relevance: 100%
- Alexandria Real Estate Equities, Inc. (NYSE: ARE) is celebrating 32 years as a leader in life science real estate, pioneering Megacampus ecosystems in key innovation clusters. The company's persistent leadership has been critical in advancing human health through mission-critical infrastructure and fostering collaborations that accelerate life science innovation, even amidst challenging market conditions. Alexandriaâ€™s robust asset base and strong tenant retention highlight its pivotal role in the discovery of groundbreaking therapies and cures, exemplified by its efforts in addressing major depressive disorder.

**4. ARE INVESTOR NOTICE: Lose Money on Alexandria Real Estate Equities, Inc.? Contact BFA Law before January 26 Securities Class Action Deadline**
- Source: ACCESS Newswire | 20260103T200742 | Bearish | Relevance: 100%
- Bleichmar Fonti & Auld LLP has filed a class action lawsuit against Alexandria Real Estate Equities, Inc. (NYSE:ARE) and its executives for alleged securities fraud. The lawsuit follows a significant stock drop after the company announced lower-than-expected results for 3Q 2025, cut guidance, and reported a substantial real estate impairment charge due to lower occupancy rates and slower leasing activity. Investors who purchased Alexandria Real Estate securities are encouraged to contact BFA Law before the January 26, 2026 deadline to potentially serve as a lead plaintiff.

**5. Alexandria Real Estate Equities, Inc. (ARE) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit**
- Source: Your Wyoming Link | 20260103T160736 | Bearish | Relevance: 100%
- Glancy Prongay & Murray LLP has announced that shareholders of Alexandria Real Estate Equities, Inc. (ARE) who incurred losses have the opportunity to serve as lead plaintiffs in a securities fraud class action lawsuit. The lawsuit alleges that Alexandria Real Estate Equities, Inc. made materially misleading statements regarding the declining value and occupancy stability of its LIC property between January 27, 2025, and October 27, 2025. Investors are encouraged to contact Glancy Prongay & Murray LLP by the January 26, 2026 deadline to participate.

### Analyst Activity

**Target Signal:** VERY_BEARISH (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-16 | Jefferies | $47 | $62 | -24% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-16 | Jefferies | main | Hold |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 6 ($0.14M) |
| Sells | 15 ($4.17M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 47.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 3 |

**Top Holders:**
- Vanguard Group Inc: 14.9% (-1.1%)
- Blackrock Inc.: 10.0% (-10.7%)
- State Street Corpora: 6.5% (+3.7%)
- Apg Asset Management: 3.9% (0.0%)
- JPMORGAN CHASE & CO: 3.3% (+34.1%)

### Key Risks

1. Insider selling cluster: $4.2M in recent transactions.
2. Valuation risk: PEG 844.2x with declining EPS estimates leaves no margin for error.
3. Long-term trend broken: trading 31.0% below SMA200.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_10 improving +1.5% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 844.20 signals overvaluation risk, limited margin of safety. Revenue declining -8% YoY, concerning. Analyst sentiment negative (1 target cuts vs 0 raises). Insider selling cluster ($4.2M in 90 days), potential headwind. Institutional flow bullish (5 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $8.6B |
| Beta | 1.32 |
| 52W Range | $44.10 - $105.14 |
| Short Interest | 5.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 844.20 |
| Forward P/E | N/A |
| Current P/E | N/A |
| YoY Growth | N/A |
| EPS Direction | FALLING |

### Technicals

MRS_10 strengthening from 1.2% to 2.7% (+1.5% in 5 days), confirming momentum buildup. Below STRENGTH zone by 0.3pp (needs >3.0% for momentum thesis). MRS_5 at 1.1% confirms short-term momentum alignment. Below SMA200 (0.69x), long-term trend not supportive. MACD histogram positive (0.69), confirming momentum. RSI neutral at 48. OFD pattern: +MUL (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 2.66% (CS: 75) | Neutral |
| RSI_14 | 48.2 | Neutral |
| MACD Histogram | 0.69 | Bullish |
| vs SMA20 | 1.039x | Above |
| vs SMA50 | 0.943x | Below |
| vs SMA200 | 0.690x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $49.53
- **Stop Loss:** $46.57 (6.0% risk)
- **Target:** $52.49 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 388
- **Position Value:** $19,217.64
- **Portfolio %:** 19.22%
- **Risk Dollars:** $1,150.00
- **Risk Per Trade:** 1.15%
- **Modifiers:** L1 115% | L2 100% | Combined 1.15x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite. VIX remains calm at 14.9 (8th percentile) with positive yield curve (+65bps) and healthy breadth (59.2%), though elevated put/call ratio (1.27) suggests institutional hedging despite surface calm. Focus on quality with awareness of hedging activity divergence.*

### Earnings

**Next:** 2026-01-26 (Est: $0.42)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.39 | $0.50 | +28.2% |
| 2025Q2 | $0.63 | $0.48 | -24.0% |
| 2025Q1 | $0.60 | $0.51 | -15.5% |
| 2024Q4 | $0.90 | $0.69 | -23.0% |

---
*RULE-based L3 | 2026-01-07 09:35 | MRS_10*